University of Florida
Gainesville, Florida, United States
Duane A. Mitchell, M.D., Ph.D. is the Phyllis Kottler Friedman Professor in the Department of Neurosurgery. He serves as Director of the UF Clinical Translational Science Institute and Co-Director of the Preston A. Wells, Jr. Center for Brain Tumor Therapy. He received his MD and PhD from Duke University Medical Center and completed post-graduate training in pathology and neuro-oncology research prior to joining the faculty at Duke as an Assistant Professor. Dr. Mitchell served as the Director of Preclinical Research at the Preston Robert Tisch Brain Tumor Center at Duke and as the Associate Director of the Duke Brain Tumor Immunotherapy Program prior to being recruited to the University of Florida in 2013. Dr. Mitchell currently leads a comprehensive neuro-oncology program focused on translational brain tumor research. He is a leading expert in the development of innovative immunotherapy treatments for adults and children with malignant brain tumors. He has pioneered many novel brain tumor immunotherapy treatments that have been translated into first-in-human clinical trials and multi-center phase 2 studies. He has received numerous awards and recognition for his work, including a 2016 Top 10 Clinical Research Achievement Award from the Clinical Research Forum in Washington, D.C, induction into the American Society for Clinical Investigation in 2019, and induction into the American Association of Physicians in 2023. Dr. Mitchell's research has been funded by the NIH, Department of Defense, and numerous private foundations, and he is inventor on over 25 patents for novel cancer therapeutics. He has served on many national and international advisory boards for industry, academia, and government agencies including the NCI Board of Scientific Counselors, Cancer Prevention and Research Institute of Texas (CPRIT), and current serves as the Co-Chair of the NCATS Clinical and Translational Science Award (CTSA) Steering Committee.
